Confluence Investment Management LLC Raises Holdings in The Clorox Company $CLX

Confluence Investment Management LLC lifted its position in shares of The Clorox Company (NYSE:CLX) by 33.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,247,644 shares of the company’s stock after acquiring an additional 315,069 shares during the quarter. Clorox makes up 1.9% of Confluence Investment Management LLC’s investment portfolio, making the stock its 13th largest position. Confluence Investment Management LLC’s holdings in Clorox were worth $119,075,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in CLX. Norges Bank bought a new stake in shares of Clorox in the fourth quarter valued at approximately $135,735,000. Invesco Ltd. boosted its holdings in Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after buying an additional 884,751 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in Clorox by 6,907.9% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after buying an additional 739,005 shares in the last quarter. Worldquant Millennium Advisors LLC purchased a new position in Clorox in the 2nd quarter valued at approximately $71,856,000. Finally, Two Sigma Investments LP raised its holdings in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after acquiring an additional 439,797 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $98.25 on Tuesday. The company has a market cap of $11.88 billion, a PE ratio of 15.95 and a beta of 0.54. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a 50-day moving average price of $95.57 and a 200-day moving average price of $103.57. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $128.90.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. During the same period in the prior year, the business earned $2.87 earnings per share. Clorox’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities analysts forecast that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date is Wednesday, August 12th. This is a boost from Clorox’s previous quarterly dividend of $1.24. Clorox’s dividend payout ratio is 80.52%.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox reported fourth-quarter adjusted earnings of $1.66 per share, exceeding the $1.64 analyst consensus, while revenue of $1.95 billion also surpassed the $1.91 billion estimate. Clorox Q4 Earnings and Revenues Surpass Estimates
• Positive Sentiment: The company forecast fiscal 2027 sales of approximately $7.6 billion to $7.7 billion, above the roughly $7.5 billion consensus. Management cited improving demand in health and wellness products and international markets despite continued macroeconomic uncertainty. Clorox Forecasts Upbeat Annual Sales as Demand Improves
• Positive Sentiment: Clorox raised its quarterly dividend to $1.25 per share from $1.24, supporting the stock’s income appeal with an indicated yield of roughly 5.2%. The dividend is payable August 28 to shareholders of record August 12.
• Neutral Sentiment: The outlook reflects recovery potential following the GOJO acquisition and completion of the U.S. enterprise-resource-planning implementation, but the integration and strategic investments may continue to affect near-term results. Clorox Reports Q4 and FY26 Results
• Negative Sentiment: Fiscal 2026 was weaker: annual sales declined 5% to $6.72 billion and diluted EPS fell 26% to $4.81. Fourth-quarter sales decreased 2%, while reported diluted EPS dropped 50% to $1.34, reflecting elevated costs and business-transition pressures. Clorox Q4 Sales Fall 2 Percent to $1.95 Billion
• Negative Sentiment: Fiscal 2027 EPS guidance of $5.70 to $6.00 is below the $6.23 analyst consensus, signaling that inflation, value-seeking consumers, acquisition costs and ongoing investments could constrain profitability even as sales recover.

Analysts Set New Price Targets

CLX has been the topic of a number of recent research reports. Wells Fargo & Company dropped their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Royal Bank Of Canada decreased their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Barclays raised their price objective on shares of Clorox from $85.00 to $86.00 and gave the company an “underweight” rating in a research report on Tuesday, July 21st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Friday, July 10th. Twelve investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $101.00.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.